Hepatocyte growth factor receptor
| GO Term |
|---|
| membrane |
| postsynapse |
| basal plasma membrane |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 45 | N-linked (GlcNAc...) asparagine |
|
||
| 106 | N-linked (GlcNAc...) asparagine |
|
||
| 201 | N-linked (GlcNAc...) asparagine |
|
||
| 357 | N-linked (GlcNAc...) asparagine |
|
||
| 398 | N-linked (GlcNAc...) asparagine |
|
||
| 404 | N-linked (GlcNAc...) asparagine |
|
||
| 581 | O-linked (Man) threonine |
|
||
| 606 | N-linked (GlcNAc...) asparagine |
|
||
| 634 | N-linked (GlcNAc...) asparagine |
|
||
| 675 | O-linked (Man) threonine |
|
| Pathway Name | Organism |
|---|---|
| Drug-mediated inhibition of MET activation | Mus musculus |
| MET Receptor Activation | Mus musculus |
| MET activates PI3K/AKT signaling | Mus musculus |
| MET activates PTK2 signaling | Mus musculus |
| MET activates PTPN11 | Mus musculus |
| MET activates RAP1 and RAC1 | Mus musculus |
| MET activates RAS signaling | Mus musculus |
| MET activates STAT3 | Mus musculus |
| MET interacts with TNS proteins | Mus musculus |
| MET receptor recycling | Mus musculus |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0060041 | autism spectrum disorder | |
| DOID:11119 | Gilles de la Tourette syndrome | |
| DOID:11714 | gestational diabetes | |
| DOID:1612 | breast cancer |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025